![Hannah Nam MD MSCI Profile](https://pbs.twimg.com/profile_images/1666922890338639872/X-jnVYk6_x96.jpg)
Hannah Nam MD MSCI
@HannahNamMD
Followers
3K
Following
7K
Statuses
3K
UC Irvine | Transplant ID | Respiratory Viruses🦠 | Med-Peds | 🇰🇷🇺🇸 대원외고 | 고려대학교 | @UUtah | @penn_state | @UICDom | @NM_IDSteward | 아미💜 since 2017
Orange County, CA
Joined June 2018
RT @ABsteward: 🔥 Just published 🔥 @IDSAInfo 2024 Guideline Update on the Risk Assessment, Diagnostic Imaging, and Microbiological Evaluatio…
0
113
0
RT @MichaelGIsonMD: Excited to see this important study being started by @esgrev_escmid - reach out to Tshafat@mdanderson.org if you want t…
0
4
0
RT @ABsteward: Myth:Bactrim is not active against β-hemolytic Streptococcus,is now totally BUSTED 🆕️🔥 @ChristianCho In vitro activity again…
0
142
0
RT @MichaelGIsonMD: 🚨 Looking to help plan ideas for ESGICH to propose for ECCMID 2025? 🚨 1. Sign up to join a planning group meeting Apr…
0
13
0
RT @AjayBhasin19: Respiratory viruses: not just for kids. RSV, hMPV, and PIV were associated with significant morbidity in adults even pre-…
0
5
0
RT @TxID_Fellows: Get ready for our next #TxIDChat on Antimicrobial Stewardship in #TxID: next week on Thursday March 14th at 7:30pEST/6:30…
0
9
0
RT @MichaelGIsonMD: Excited to have our ESGICH-picked case as the next CPC! Join us at 3pm Central European Time @ESCMID What do you thin…
0
14
0
RT @TheTxIDjournal: Got research related to donor-derived infections? Not too late to submit your data as a submission for consideration i…
0
9
0
RT @martinhoenigl: Therapeutic drug monitoring of antifungal therapies: do we really need it and what are the best practices? @krielisa_ an…
0
29
0
RT @MichaelGIsonMD: Being a mentor is among the best "jobs" in the world. This is a great read about the incredible things mentors can do…
0
2
0
RT @MichaelGIsonMD: Are you focused on Infections in Immunocompromised Hosts (#TxID)? Are you a member of @ESCMID? Make sure you are a me…
0
8
0
RT @RicardoLaHozMD: 1/2 January 2024 @AST_info @AST_IDCOP Article of the Month - SARS-CoV-2 viral clearance and evolution varies by type an…
0
5
0
RT @TransplantIDNet: "Vaccine schedule recommendations and updates for patients with hematologic malignancy post-hematopoietic cell transpl…
0
23
0
RT @IDWeekmtg: MAXWELL FINLAND LECTURE SPEAKER ANNOUNCEMENT! IDWeek is excited to announce that @EmilyBlumbergMD, Director of the Transplan…
0
18
0
RT @WestTxID: Block your calendars for our next West Coast Transplant ID Virtual Meeting on September 6th! @HannahNamMD @DeepaDNanayakk1 w…
0
4
0
RT @PaulSaxMD: Impressive virologic analysis of SARS-CoV-2 clearance comparing different pts with varying immunocompromising conditions. H…
0
18
0